In response to recent pertussis resurgence, a multi-agency recommendation that students receive a one-time Tdap vaccine was introduced. Post mandate there was sequential increase in the Tdap vaccine uptake in the targeted population.
Brief
Pertussis (whooping cough) is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. It was one of the common childhood diseases and a major cause of childhood mortality in the United States in the 20 th century before the introduction of the vaccine. The pertussis vaccine was first introduced in the 1940s initially as a whole-cell pertussis vaccine and became available combined with diphtheria and tetanus toxoids (as DTP) in 1948 [1] . The pertussis vaccine is now given with early childhood immunizations as the acellular pertussis vaccine in combination with tetanus and diphtheria toxoid as DTaP introduced in the 1990s [1] . A cellular pertussis-containing vaccines (Tdap)
were first licensed for adolescents and adults in 2005 [1] . Protection however, from these vaccines begins to wane over time and puts pre-teens, teenagers, and adults at risk for the illness resulting in intermittent outbreaks. Since the introduction of the vaccine in the 1940s, with national case counts in the 100,000s per year, case counts declined to the 1000s in the 1970s and early 1980s [2] . The 
